christine Brefel-courbon
christine Brefel-courbon
MCU PH, Neuropharmacologie, CHU Toulouse; TONIC (INSERM UT3); TMBI Univ Toulouse
Verified email at
Cited by
Cited by
Neurostimulation for Parkinson's disease with early motor complications
WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ...
New England Journal of Medicine 368 (7), 610-622, 2013
A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe
N Abbas, CB Lücking, S Ricard, A Dürr, V Bonifati, G De Michele, ...
Human molecular genetics 8 (4), 567-574, 1999
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study
C Brefel‐Courbon, P Payoux, C Thalamas, F Ory, I Quelven, F Chollet, ...
Movement disorders: official journal of the Movement Disorder Society 20 (12 …, 2005
Limitations of current Parkinson's disease therapy
O Rascol, P Payoux, F Ory, JJ Ferreira, C Brefel‐Courbon, JL Montastruc
Annals of Neurology: Official Journal of the American Neurological …, 2003
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ...
Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003
Longitudinal analysis of impulse control disorders in Parkinson disease
JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ...
Neurology 91 (3), e189-e201, 2018
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo …
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The lancet neurology 11 (7), 589-596, 2012
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy
C Brefel‐Courbon, P Payoux, F Ory, A Sommet, T Slaoui, G Raboyeau, ...
Annals of neurology 62 (1), 102-105, 2007
Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro‐Saint Paul, C Brefel‐Courbon, M Vidailhet, ...
Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001
α-Synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms
P Ibáñez, S Lesage, S Janin, E Lohmann, F Durif, A Destée, AM Bonnet, ...
Archives of neurology 66 (1), 102-108, 2009
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
R Vidal, B Ghetti, M Takao, C Brefel-Courbon, E Uro-Coste, BS Glazier, ...
Journal of Neuropathology & Experimental Neurology 63 (4), 363-380, 2004
Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management
JM Senard, C Brefel-Courbon, O Rascol, JL Montastruc
Drugs & aging 18, 495-505, 2001
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial
F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ...
Neurology 82 (4), 300-307, 2014
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects
M Periquet, CB Lücking, JR Vaughan, V Bonifati, A Dürr, G De Michele, ...
The American Journal of Human Genetics 68 (3), 617-626, 2001
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ...
The Lancet Neurology 16 (8), 620-629, 2017
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial …
E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ...
The Lancet Neurology 17 (3), 223-231, 2018
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
F Ory‐Magne, C Brefel‐Courbon, M Simonetta‐Moreau, N Fabre, ...
Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007
Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: A clinical survey in PD patients and age‐matched healthy volunteers
JJ Ferreira, K Desboeuf, M Galitzky, C Thalamas, C Brefel‐Courbon, ...
European journal of neurology 13 (3), 209-214, 2006
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study
JL Montastruc, C Brefel-Courbon, JM Senard, H Bagheri, J Ferreira, ...
Clinical neuropharmacology 24 (3), 181-183, 2001
The system can't perform the operation now. Try again later.
Articles 1–20